Goodbody Health Ltd. has introduced its New Mobile Phlebotomy Service. This service will help in expanding and increasing the reach of phlebotomy testing,
Blood is drawn from a vein using a needle during phlebotomy to be tested at a lab.
The Need for New Mobile Phlebotomy Service
The company stated in a statement that by providing a mobile service, testing can be done in the patient’s home or other convenient locations, satisfying the needs of individuals unable to travel.
Aquis-listed According to Goodbody, the service has been “extremely successful,” with more than 120 phlebotomists applying to work on the platform and patients choosing this approach to collect samples.
The delivery of UK health services, including diagnostics, through partnerships and creative third-party solutions, we believe will lead to market growth for all participants, said Goodbody Chief Executive Officer George Thomas in the announcement.
Also Read: https://thecitizenscoop.com/powerful-medical-announced-the-launch-of-pmcardio-in-the-uk/
The group added that the deployment of Trucheck is proceeding “excellent” because of its cooperation with Datar Cancer Genetics, launched in January.
Trucheck is a liquid biopsy product designed by Goodbody and Datar for Circulating Tumour Cell multi-cancer screening.
Goodbody claimed that during the product’s initial soft-launch period, there was a lot of interest in it, showing that it might be a “major revenue stream for the company.”
In addition to the five testing suppliers announced on January 31 and February 15, 2023, further phlebotomy contracts have been struck with four other testing companies who want to work with Goodbody Clinics as a phlebotomy partner.
